Suppr超能文献

[劳卡尼——一种新型抗心律失常药物的电生理检查]

[Lorcainid--electrophysiologic examinations of a new anti-arrhythmia agent].

作者信息

Gstöttner M, Ng C K, Gmeiner R

出版信息

Acta Med Austriaca. 1978;5(4-5):137-8.

PMID:756123
Abstract

The electrophysiologic properties of Lorcainide (1.25 and 2.5 mg/kg) were studied on 21 patients by intracardiac electrograms and atrial stimulation. A prolongation of the H-V interval, widening of QRS duration but only minor changes in A-H interval were found. The effective refractory period of the atria increased, the effective and functional refractory periods of the A-V node changed variable following Lorcainide. There was a slight increase in heart rate and the sinus node recovery time was longer after 2.5 mg/kg of the drug. The major site of action of Lorcainide in man appears to be the His-Purkinje system. In electrophysiologic terms the new antiarrhythmic agent closely resembles Aprindine.

摘要

通过心内电图和心房刺激对21例患者研究了劳卡尼(1.25和2.5mg/kg)的电生理特性。发现H-V间期延长、QRS时限增宽,但A-H间期仅有轻微变化。心房有效不应期延长,房室结的有效和功能不应期在使用劳卡尼后变化不定。心率略有增加,给予2.5mg/kg该药后窦房结恢复时间延长。劳卡尼在人体的主要作用部位似乎是希氏-浦肯野系统。从电生理角度来看,这种新型抗心律失常药物与安搏律定非常相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验